KOL Commentary

ESMO 2023 Coverage - Part 3

Prof. Barrios and Prof. Harbeck discuss and summarize the new endocrine therapies in the metastatic setting.

Start typing and press enter to search

This site is only for use by healthcare professionals. By continuing to view this site you are confirming that you are a healthcare professional.

CONFIRM